Ophthalmoplegia Industry Report 2025: Market Overview, Trends & Competitive Landscape

30 Apr, 2025

The Ophthalmoplegia Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Ophthalmoplegia Market?

The market size of the ophthalmoplegia sector has seen swift expansion in recent times. It is projected to inflate from $1.68 billion in 2024 to $1.85 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Ophthalmoplegia Industry?

The Ophthalmoplegia Global Market Report 2025 projects that by 2029, the market will grow to $2.72 billion, expanding at a compound annual growth rate of 10.1%.

Download Your Free Sample of the 2025 Ophthalmoplegia Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Ophthalmoplegia Market?

The key drivers in the ophthalmoplegia market are:

• Rising prevalence of neurological disorders affecting eye movement
• Increase in the global aging population
• Growing awareness about eye movement disorders
• Strategic collaborations and increased investment in healthcare by key stakeholders

Global Market Segmentation: Identifying Major Ophthalmoplegia Industry Segments

The ophthalmoplegia market covered in this report is segmented –
1) By Type: External Opthalmoplegia, Internuclear Opthalmoplegia
2) By Treatment: Surgery, Drug Treatment
3) By End-User: Hospitals, Clinics, Ambulatory Clinics Subsegmentss:
1) By External Ophthalmoplegia: Chronic Progressive External Ophthalmoplegia (CPEO), Myasthenic External Ophthalmoplegia, Mitochondrial Myopathy-Associated External Ophthalmoplegia
2) By Internuclear Ophthalmoplegia: Unilateral Internuclear Ophthalmoplegia, Bilateral Internuclear Ophthalmoplegia

Pre-order the 2025 Ophthalmoplegia Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Ophthalmoplegia Market?

The key trends in the ophthalmoplegia market are:

• Advancements in diagnostic technologies are becoming prevalent.
• The industry is seeing development of novel therapeutic approaches for treatment.
• Strategic collaborations and partnerships are influencing the market.
• Technological advancements in eye tracking devices and development of muscle-strengthening drugs are new emerging trends.

Who Are the Top Competitors & Leading Players in the Ophthalmoplegia Market?

Major players in the ophthalmoplegia market are:

• Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Novartis AG
• Medline Industries Inc.
• Regeneron Pharmaceuticals Inc.
• Carl Zeiss AG
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Limited
• Bayer AG
• Santen Pharmaceutical Co. Ltd.
• Oculis Holding AG
• Innovative Pharmaceuticals Pvt. Ltd.
• Clearside Biomedical Inc.
• Altacor Limited
• Azura Ophthalmics Ltd.
• ViGeneron GmbH
• Amritt Inc.
• GenSight Biologics SA
• EyeBio Inc.
• Opthea Limited

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the ophthalmoplegia market in 2024